Novartis – Faulty Drugs

Drug Recalls FDA Advisory Valsartan

Valsartan recalled for cancer link

July 7, 2018July 7, 2018 film-coated tablets, HCT, N-Nitrosodimethylamine, NDMA, Novartis, Sandoz valsartan

The heart drug valsartan is being recalled in 22 countries. It contains a chemical that poses a potential cancer risk.

Blood pressure medications linked to increased risk of cancer

June 12, 2010June 14, 2010 Amias, angiotensin-receptor, Aprovel, ARB, Atacand, Avapro, Benicar, Blood pressure, Blopress, Candesartan, Cozaar, Diovan, Irbesartan, Karvea, Losartan, Micardis, Novartis, Olmesartan, Olmetec, Ratacand, Telmisartan, Valsartan

According to a study published in the British medical journal The Lancet Oncology, certain blood pressure medications may be linked to